PharmaLink Conference

PharmaLink会议

• 批准号: 10828206
• 负责人: Steven Mandernach
• 金额: $ 5万
• 依托单位: ASSOCIATION OF FOOD AND DRUG OFFICIALS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-01 至 2028-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10828206
• 关键词: PharmaLink; Conference

Project Summary The key objectives of the PharmaLink Conference are:  Open collaboration and engagement with FDA and industry to discuss pharmaceutical challenges and opportunities.  Identify innovative solutions for rising issues in the pharmaceutical industry and across healthcare. AFDO proposes the PhamaLink Conference plan to follow this format:  During years 2023-2024 there will be an in-person conference with presentations and facilitated discussions on identifying and building innovative and collaborative solutions to be used in the pharmaceutical industry to advance patient care. During each conference, a group of 130+ Pharmaceutical leaders from all areas of the industry will come together to lead innovation around the issues surfaced during the collaborative opportunities between industry and regulators.

项目摘要 PharmaLink会议的主要目标是： 与FDA和行业开放合作和参与，讨论制药挑战， 机会 为制药行业和整个医疗保健领域的新兴问题确定创新解决方案。 AFDO建议PhamaLink会议计划遵循以下格式： 在2023-2024年期间，将举办一次现场会议，进行演讲并提供便利 讨论如何确定和建立创新的协作解决办法， 制药行业，以推进病人护理。 在每次会议期间，来自行业各个领域的130多位制药领导人将出席 共同围绕合作机会中出现的问题进行创新， 行业和监管机构。